Canventol

N/A

Report date: 2022/08/23 20:00:44
NME

Base Information

Drug NameCanventol
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor inhibitors
TargetsTumor necrosis factor
Therapy Area/IndicationsNeoplasmsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMitsubishi Chemical
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMitsubishi Chemical +[2] 
Active IndicationsN/A
Inactive IndicationsNeoplasmsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A